Cargando…

Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study

Background: To determine the safety and efficacy of corticosteroids (CS) combined with cyclophosphamide (CTX), compared with CS combined with mycophenolate mofetil (MMF) for IgA nephropathy (IgAN) patients with stage 3 and 4 CKD and proteinuria ≥1.0 g/24 h in a 10-year real-world study. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Qing, Ma, Feng, Zhao, Jin, Yang, Xiaoxia, Sun, Ruiling, Li, Rong, Sun, Shiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471000/ https://www.ncbi.nlm.nih.gov/pubmed/36120326 http://dx.doi.org/10.3389/fphar.2022.946165

Ejemplares similares

Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study
por: Samsonov, Dmitry, et al.
Publicado: (2022)

Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015)

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014)

Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
por: Du, Bing, et al.
Publicado: (2017)

A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
por: Hogg, Ronald J, et al.
Publicado: (2004)

Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials
por: Zheng, Jian-Nan, et al.
Publicado: (2018)

The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease
por: Yang, Xiaoxia, et al.
Publicado: (2021)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports
por: Zhao, Jin, et al.
Publicado: (2021)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
por: Zhang, Xuebing, et al.
Publicado: (2020)

Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report
por: Khanal, Sushil, et al.
Publicado: (2021)

Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
por: Seo, Jung-Woo, et al.
Publicado: (2015)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

Ciclosporin/cyclophosphamide/mycophenolate mofetil: Bacterial, viral and fungal infections: 71 case reports
Publicado: (2019)

An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
por: Huang, Xin, et al.
Publicado: (2021)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
por: Li, Huixian, et al.
Publicado: (2021)

A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
por: Chen, Shasha, et al.
Publicado: (2018)

PK/PD Study of Mycophenolate Mofetil in Children With Systemic Lupus Erythematosus to Inform Model-Based Precision Dosing
por: Chen, Yewei, et al.
Publicado: (2020)

Complete remission of nephrotic syndrome and acute kidney injury in crescentic IgA nephropathy: Role of mycophenolate sodium
por: Bhandari, D., et al.
Publicado: (2016)

Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
por: Luo, Lei, et al.
Publicado: (2012)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Cyclophosphamide/methylprednisolone/mycophenolate mofetil: COVID-19 and herpes zoster infection: 2 case reports
Publicado: (2022)

Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats
por: XIAO, XIAOYAN, et al.
Publicado: (2015)

Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetil
por: Oliveira, Luiza Barbosa, et al.
Publicado: (2017)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
por: Sieradzka, Agnieszka Ewa, et al.
Publicado: (2022)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
por: Blagova, Olga, et al.
Publicado: (2023)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022
por: Guo, Yun, et al.
Publicado: (2023)

Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
por: Liu, Caiqiong, et al.
Publicado: (2021)

Corticosteroids in Patients with IgA Nephropathy and Severe Chronic Renal Damage
por: Pozzi, Claudio, et al.
Publicado: (2012)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Park, Seung Woon, et al.
Publicado: (2016)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
por: Zhao, Lijuan, et al.
Publicado: (2023)

Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007–2012)
por: Woolcock, Andrew D., et al.
Publicado: (2016)

Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis
por: Nakano, Kenji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qvfekv2gnm4tb1run5cppge6h